http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2327884-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b324629cd304556767c08c014527e512 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-736 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-736 |
| filingDate | 1999-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3d45a3f9cbf2b137c58cc6b3c0ae1a9 |
| publicationDate | 1999-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2327884-A1 |
| titleOfInvention | Novel therapeutic agents interfering in neutrophil migration |
| abstract | The present invention provides methods and means to influence neutrophil migration which occurs in a number of serious illnesses, such as acute trauma and inflammatory diseases. In bacterial meningitis for instance a high influx of neutrophils in the brain leads to an unfavourable prognosis. Typically IL-8 is involved in chemoattracts of neutrophils. According to the present invention glucoronoxylmannan or a functional equivalent thereof is used to interfere with neutrophil migration. This constitutes a first medical use of this group of substances. |
| priorityDate | 1998-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 222.